20mg x 30 pills
|54.45 EUR||1.82 EUR|
20mg x 90 pills
|154.28 EUR||1.71 EUR|
20mg x 180 pills
|272.27 EUR||1.51 EUR|
20mg x 360 pills
|453.79 EUR||1.26 EUR|
Availability: In Stock
Manufacturer: Eticos Pharma
Generic or Brand: Generic
Prescription Required: No
Basic Facts About Acomplia (Rimonabant)
Acomplia, with the generic name of Rimonabant, is essentially an anorectic anti-obesity medication. This drug is an antagonist of the CB1 cannabinoid receptor. The main effect this drug has to the patient would be a significant reduction in appetite.
How Acomplia (Rimonabant) Works
Acomplia functions through blocking the receptors of the substance which is called cannabinoid 1. This particular substance is the one that stimulates hunger as well as other cravings in the human brain and can also be found in fat tissues. So as this Rimonabant drug is administered, the individual would automatically be eating less as he or she would not be able o feel any hunger. The effect would be less food intake, helping in the reduction of the individual’s cholesterol levels.
It is important to note that as an individual starts to lose weight, the first area that body fat would be reduced would be in the mid-section. Cholesterol levels would also be going down, together with the blood pressure returning to healthier and more stable levels.
Dosage for Acomplia (Rimonabant)
The typical dose for Acomplia would be a single 20 mg tablet that could be taken once a day before breakfast in the morning. The tablet must be swallowed in whole.
Side Effects of Acomplia (Rimonabant)
Acomplia has been studied to be a very tolerable drug. The only possible side effects were some dizziness and mild gastro-intestinal problems. However, these particular side effects were said to be temporary and not prolonged.
Acomplia (Rimonabant) Storage
Acomplia needs to be kept at a room temperature of not over 77 degrees F or 25 degrees C and should be kept inside a container which has been tightly closed. This drug also has to be kept from humidity and from children’s reach.
Additional Information For Acomplia (Rimonabant)
In a clinical test that has been conducted, it was found that this drug was effective in helping smoker to quit smoking. In fact, it was studied that there exists a direct relation between the increased risk for cardiovascular diseases, diabetes, breast and colorectal cancer and obesity. Increase in an individual’s body weight could lead to changes in cholesterol and blood lipid levels, and could eventually lead to an increased risk for